Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
Frequently asked questions
What sector does Carasent ASA (CARA) operate in?
Carasent ASA belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Carasent ASA (CARA) current stock price?
As of the latest data, Carasent ASA stock price is NOK 21.10, with a previous close of NOK 21.10.
What is Carasent ASA (CARA) current market capitalization?
Carasent ASA market cap is approximately 1.53 billion.
What is Carasent ASA (CARA) Earnings Per Share (EPS)?
The trailing EPS is -NOK 0.14, and the forward EPS is NOK 0.37.
Does Carasent ASA (CARA) pay dividends?
No. Carasent ASA does not pay a dividend.
What is Carasent ASA (CARA) beta (volatility) score?
Carasent ASA has a beta of 0.497, indicating lower volatility than the overall market.
